Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet Corvol

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Orphanet Journal of Rare Diseases|June 19, 2012
A national internet-linked based database for pediatric interstitial lung diseases: the French networkNadia Nathan, Rola Abou Taam, Ralph Epaud, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2020
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational studyRobert Bain, Rebecca Cosgriff, Marco Zampoli, et al.
Nature Genetics|April 3, 2012
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosisLei Sun, Johanna M Rommens, Harriet Corvol, et al.
Pediatric Pulmonology|October 15, 2025
Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare CohortManon Fleury, Céline Delestrain, Alice Hadchouel, et al.
The New England Journal of Medicine|July 10, 2024
Nirsevimab and Hospitalization for RSV BronchiolitisZein Assad, Anne-Sophie Romain, Camille Aupiais, et al.
Nature Communications|September 30, 2015
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosisHarriet Corvol, Scott M Blackman, Pierre-Yves Boëlle, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2020
The global impact of SARS-CoV-2 in 181 people with cystic fibrosisElliot McClenaghan, Rebecca Cosgriff, Keith Brownlee, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2023
Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 PatientsYi-Hui Zhou, Paul J Gallins, Rhonda G Pace, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2022
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational studySiobhán B Carr, Elliot McClenaghan, Alexander Elbert, et al.
The Lancet Regional Health. Europe|November 12, 2025
Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control studyApolline Furgier, Camille Brehin, Corinne Levy, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Orphanet Journal of Rare Diseases|June 19, 2012
A national internet-linked based database for pediatric interstitial lung diseases: the French networkNadia Nathan, Rola Abou Taam, Ralph Epaud, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2020
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational studyRobert Bain, Rebecca Cosgriff, Marco Zampoli, et al.
Nature Genetics|April 3, 2012
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosisLei Sun, Johanna M Rommens, Harriet Corvol, et al.
Pediatric Pulmonology|October 15, 2025
Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare CohortManon Fleury, Céline Delestrain, Alice Hadchouel, et al.
The New England Journal of Medicine|July 10, 2024
Nirsevimab and Hospitalization for RSV BronchiolitisZein Assad, Anne-Sophie Romain, Camille Aupiais, et al.
Nature Communications|September 30, 2015
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosisHarriet Corvol, Scott M Blackman, Pierre-Yves Boëlle, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2020
The global impact of SARS-CoV-2 in 181 people with cystic fibrosisElliot McClenaghan, Rebecca Cosgriff, Keith Brownlee, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2023
Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 PatientsYi-Hui Zhou, Paul J Gallins, Rhonda G Pace, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2022
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational studySiobhán B Carr, Elliot McClenaghan, Alexander Elbert, et al.
The Lancet Regional Health. Europe|November 12, 2025
Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control studyApolline Furgier, Camille Brehin, Corinne Levy, et al.
Pageof 15